Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Explore ways to earn money on the side. Find effective strategies that can help you increase your income without a full-time commitment.
13,964 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
When markets slump, two crypto giants throw up different signals. This guide breaks down the case for Bitcoin as the ...
As Dyadic gears up to report dyadic (dyai) 2025 earnings, investors should focus on revenue mix, cash runway, and par...
VFVA has posted solid gains by targeting cheap U.S. equities, but a hidden volatility risk lies in its deep value app...
One of Wall Street’s hottest hedge funds is riding a two-trade surge, concentrated in Nvidia and Meta Platforms, as i...
A rough week for stocks left many investors wonder what comes next. This guide breaks down why the Dow tumbled and th...
World Liberty Financial filed a defamation lawsuit in Florida against Justin Sun, who dismissed the filing as meritle...
As confirmation hearings approach, kevin warsh’s undisclosed wealth becomes a flashpoint, with a 69-page filing leavi...
Micron Technology has captured investor attention with a dramatic price rally. This guide breaks down what a stock sp...
Bank of America signals a noticeable pullback in card use across its customers, adding to a growing picture of cautio...
The Trade Desk has faced a tough stretch, but patient investors are asking if the trade desk stock finally offers a p...
Traders on the solana-based meme coin launchpad Pump.fun reverse losses in 2026 as profitability climbs, per CoinGeck...